1,051 results match your criteria: "Centre de Recherche sur l'Inflammation[Affiliation]"
Blood
June 2025
Université de Paris, INSERM-U1149, CNRS-ERL8252, Centre de Recherche sur l'Inflammation (CRI), PARIS, France.
Neutrophils play a key role in innate immunity by killing microbes through phagocytosis and superoxide anion production by the phagocyte NADPH oxidase. The signaling pathways regulating NADPH oxidase activation in neutrophils have been extensively studied using soluble agonists, but are less understood during phagocytosis, a fundamental function of neutrophils. The aim of this study was to investigate the phosphorylation of the cytosolic NADPH oxidase protein p47phox in human neutrophils stimulated by serum-opsonized zymosan (OZ), which induces phagocytosis, using antibodies against phosphorylated sites.
View Article and Find Full Text PDFEur Radiol
June 2025
Université Paris Cité, INSERM, Centre de recherche sur l'inflammation, Paris, France.
Objectives: To evaluate the performance of the ultrasound hepatorenal index (US-HRI) for the diagnosis of hepatic steatosis in patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD), using MRI proton density fat fraction (MRI-PDFF) as reference.
Materials And Methods: This two-center prospective study included 129 and 263 patients in the training and validation cohorts, respectively, between 2019 and 2022. Hepatic steatosis was classified according to MRI-PDFF as S0 (≤ 6.
Obesity (Silver Spring)
August 2025
Centre de Recherche Translationnelle en Médecine Moléculaire, UMR 1231 INSERM/Université de Bourgogne/Institut Agro Dijon, Dijon, France.
Objective: Fat taste sensitivity has been implicated in long-term weight loss after bariatric surgery. Unexpectedly, improvement of orosensory fat acuity was not systematic in operated patients.
Methods: Obesity-induced alterations of gene expression in gustatory papillae having been recently reported, we have explored the fungiform transcriptomic activity in the bariatric surgery context.
Surgery
August 2025
Department of HPB Surgery and Liver Transplantation, DMU DIGEST, Beaujon Hospital, AP-HP, Clichy, France; Université de Paris Cité, Paris, France; Centre de Recherche sur l'Inflammation, INSERM Unité Mixte de Recherche 1149, Clichy, France. Electronic address:
Background: Laparoscopic central pancreatectomy (LCP) is usually proposed for non-malignant neck-body neoplasms, but it can be proposed for head-neck lesions to avoid pancreaticoduodenectomy or for body-tail lesions to avoid distal pancreatectomy. The aim of this study was to classify CP on the basis of the proximal resection level.
Method: We retrospectively studied all consecutive LCPs performed in our institution from 2011 to 2024.
Gut
June 2025
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center, Department of Infectious Diseases, The First Affiliated Hospital, Zhejiang University
Hepatol Commun
July 2025
Biochemistry and Molecular Genetics Service, Hospital Clínic-IDIBAPS and CIBERehd, Barcelona, Spain.
Background: Acute-on-chronic liver failure (ACLF), which develops in patients with acutely decompensated cirrhosis, is characterized by multiple extrahepatic organ failures leading to high short-term mortality. Although major advances in the understanding of ACLF have been accomplished in the last years, the understanding of driving mechanisms underlying ACLF is hindered by the lack of proper animal models that faithfully reproduce both the systemic hyperinflammatory response and the full spectra of extrahepatic organ failures present in this condition.
Methods: ACLF was induced by acute induction of polymicrobial peritonitis secondary to the ligation and puncture of the cecum (CLP) in mice with chronic carbon tetrachloride (CCl4)-induced cirrhosis.
JHEP Rep
June 2025
Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium.
Background & Aims: Data on changes in liver sinusoidal endothelial cells (LSECs) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and their response to treatment are limited. This study aimed at determining (i) features associated with LSEC capillarisation in patients with MASLD; (ii) whether LSEC changes can regress with the pan-peroxisome proliferator-activated receptor (PPAR) agonist lanifibranor; (iii) the role of the different PPAR isotypes on LSEC changes in MASLD.
Methods: We analysed CD34 expression, a marker of LSEC capillarisation, on liver biopsies from patients considered for inclusion in the NATIVE trial at baseline (n = 249), and after 24 weeks of placebo or lanifibranor (n = 173).
Eur Respir J
June 2025
Immune Health Laboratory, Regulation of Host Responses and Immune Health, IRL2029, French National Centre for Scientific Research (CNRS) and Ribeirão Preto Medical School (FMRP) of the São Paulo University (USP), São Paulo, Brazil
Clin Gastroenterol Hepatol
June 2025
Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Christian Doppler Lab for Po
Background & Aims: Copeptin, an arginine-vasopressin biomarker, may confer prognostic information in patients with advanced chronic liver disease (ACLD).
Methods: Patients with ACLD included in the Vienna Cirrhosis Study (NCT03267615) between January 2017 and April 2023 and available copeptin levels were prospectively recruited and classified into 6 predefined clinical ACLD stages from S0 (subclinical portal hypertension) to S5 (further decompensation). A prognostic score (MELD-copeptin score) in patients with decompensated ACLD (dACLD) was developed in a derivation cohort (n = 150) and validated in an internal (n = 148) and an external validation cohort (n = 771).
Inflammopharmacology
July 2025
Faculté de Médecine Xavier Bichat, Centre de Recherche sur l'Inflammation, Laboratoire d'excellence Inflamex, Université de Paris INSERM U1149, CNRS EMR 8252, 75018, Paris, France.
Bee venom (BV) is a complex bioactive mixture known for its paradoxical ability to exert both pro-inflammatory and anti-inflammatory effects, making it a compelling modulator of inflammatory responses. In this study, we investigated the effect of BV on human neutrophil inflammatory functions in vitro and its effect on inflammation in vivo in rats. Results revealed that BV exhibited a dose-dependent inhibitory effect on formyl-Met-Leu-Phe (fMLF)-induced superoxide production by neutrophils, without affecting PMA-induced superoxide production or superoxide production by the xanthine-xanthine oxidase system.
View Article and Find Full Text PDFJ Transl Autoimmun
June 2025
Université Paris Cité, Centre de recherche sur l'inflammation, INSERM UMR1149, CNRS EMR8252, Laboratoire d'Excellence Inflamex, Paris, France.
Systemic lupus erythematosus (SLE) activity decreases in some patients with end-stage kidney disease (ESKD). The impact of ESKD on the immune cell profile of SLE patients and lupus activity remains unclear. In this study, we aimed at characterizing immunologically inactive and active SLE patients undergoing dialysis therapy.
View Article and Find Full Text PDFHPB (Oxford)
August 2025
Department of HPB Surgery and Liver Transplantation, DMU DIGEST, Beaujon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University of Paris, 100 Boulevard du Général Leclerc, 92110, Clichy, France; University of Paris Cité France.
Background: Distal pancreatectomy with celiac axis resection (DP-CAR) carries severe morbidity and risk of gastric and liver ischemia. We present the results of three axis embolization of celiac axis (CA) before DP-CAR.
Methods: A prospectively maintained single-institution database was queried for patients operated on for potentially resectable locally advanced pancreatic cancer (LAPC) invading the CA.
AJR Am J Roentgenol
May 2025
Department of Ultrasound, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, China.
Despite growing clinical use of contrast-enhanced ultrasound (CEUS), inconsistency remains in the modality's role in clinical pathways for hepatocellular carcinoma (HCC) diagnosis and management. This AJR Expert Panel Narrative Review provides practical insights on the use of CEUS for the diagnosis of HCC across populations, including individuals at high risk for HCC, individuals with metabolic dysfunction-associated steatotic liver disease, and remaining individuals not at high risk for HCC. Considerations addressed with respect to high-risk patients include CEUS diagnostic criteria for HCC, use of CEUS for differentiating HCC from non-HCC malignancy, use of CEUS for small (≤2 cm) lesions, use of CEUS for characterizing occult lesions on B-mode ultrasound, and use of CEUS for indeterminate lesions on CT or MRI.
View Article and Find Full Text PDFTranspl Int
May 2025
Department of Anaesthesiology and Critical Care, Beaujon Hospital, DMU Parabol, AP-HP Nord, and Université Paris Cité, Paris, France.
Infections remain a main cause of morbidity and mortality following orthotopic liver transplantation (OLT). Patients with end-stage liver cirrhosis exhibit a deregulation of their immune response, making them more susceptible to infections. From a prospective database, we retrospectively assessed the ability of preoperative lymphopenia, as a marker of this immune dysregulation, to predict the occurrence of early postoperative bacterial infections during post-OLT ICU hospitalization in patients with cirrhosis.
View Article and Find Full Text PDFClin Nutr
July 2025
Centre de Recherche sur l'Inflammation (CRI), INSERM U1149, Université Paris Cité, 75018 Paris, France; Gastroenterology and Nutritional Support Department, Hôpital Beaujon (AP-HP), Clichy, France. Electronic address:
Background: Teduglutide, a glucagon-like peptide-2 (GLP-2) analog, is indicated to treat short bowel syndrome (SBS) since 2015. It has been shown to reduce parenteral support (PS) in SBS patients, although patients' response is quite heterogeneous. The exact mechanisms of action of GLP-2 on intestinal cells are still poorly understood.
View Article and Find Full Text PDFEncephale
May 2025
UMR 1253, iBraiN, Inserm, université de Tours, Tours, France; Clinique psychiatrique universitaire, centre expert dépression résistante, CHRU de Tours, Tours, France. Electronic address:
Background: Current antidepressants have shown certain limitations in the treatment of unipolar depression. Their long onset of action, interactions, and side effects are obstacles to achieving lasting remission of this prevalent, often chronic or recurrent, pathology. Faced with this clinical necessity, research efforts have intensified in recent years around psychedelic drugs, with a particular focus on the mental health benefits of psilocybin.
View Article and Find Full Text PDFObesity (Silver Spring)
July 2025
Universite Paris Cité, Paris, France.
Objective: The objective of this study is to identify whether the glucagon-like peptide-1 receptor (GLP1R) gene variant rs6923761G→A has an influence on semaglutide response in individuals with severe obesity.
Methods: From March 2023 to July 2024, we prospectively genotyped 112 patients treated with semaglutide 2.4 mg weekly.
Lupus
June 2025
Service de Médecine Interne, Hôpital Bichat-Claude Bernard, Assistance Publique - Hôpitaux de Paris, Université Paris Cité, Paris, France.
ObjectivesPrediction models based on traditional risk factors underestimate the risk for cardiovascular events (CVE) in SLE. We aimed to assess the occurrence of CVE in SLE patients according to their baseline subclinical atherosclerosis status.MethodsCarotid intima-media thickness at the carotid bulb level (CIMT) was prospectively assessed in consecutive SLE patients followed in our national reference center for rare diseases by a single evaluator, between February 2012 and February 2013.
View Article and Find Full Text PDFAJR Am J Roentgenol
July 2025
Université Paris Cité, INSERM, Centre de Recherche Sur l'Inflammation, Paris, France.
Int J Mol Sci
April 2025
Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.
TGF-β is a pleiotropic cytokine with both stimulatory and inhibitory effects on immune cells, depending on the microenvironmental context. It targets mast cells (MCs) in different physio-pathological conditions, such as inflammation and cancer. Besides acting as a potent chemoattractant for MCs, TGF-β regulates many other aspects of MCs' physiology, including the secretion of many regulatory molecules.
View Article and Find Full Text PDFLupus Sci Med
May 2025
Department of Nephrology, Bichat Hospital, APHP, Centre de Recherche sur l'Inflammation/ INSERM UMR1149/ CNRS EMR8252, Université Paris Cité, Paris, France
Eur Radiol
May 2025
Department of HPB surgery & Liver Transplantation, AP-HP, Beaujon Hospital, Clichy, France.
FASEB Bioadv
May 2025
IRSD, Université de Toulouse, INSERM, INRAE, ENVT, Univ Toulouse III - Paul Sabatier (UPS) Toulouse France.
Inflammatory bowel diseases are chronic inflammatory conditions with growing prevalence in western populations. Iron is an essential component of erythrocytes hemoglobin. Under the influence of elevated hepcidin production, iron is sequestered in cells during inflammation which, in turn, leads to iron restriction for red blood cell synthesis.
View Article and Find Full Text PDFTransplant Direct
May 2025
European Foundation for the Study of Chronic Liver Failure (EF CLIF), Barcelona, Spain.
Background: Adult solid organ transplant recipients (SOTRs) have decreased responsiveness to severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) vaccination and higher incidence of infection, but there are few data on the serological response in pediatric SOTR. The aim of this study was to determine serological response to SARS-CoV-2 vaccination in pediatric liver (LT) and kidney transplant (KT) recipients and compare it with adult SOTR.
Methods: A European, prospective, multicenter study was performed.
Liver Int
June 2025
Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Splanchnic vein thrombosis (SVT) can be associated with liver cirrhosis or prothrombotic conditions, including myeloproliferative disorders, intra-abdominal inflammation, solid cancers or surgery. While anticoagulation therapy improves outcomes in noncirrhotic patients and reduces all-cause mortality in cirrhotic populations, its safety in patients with a history of portal hypertension (PH)-related bleeding is less clear. This systematic review examines the impact of anticoagulant therapy on rebleeding risk in SVT patients with a history of PH-related bleeding.
View Article and Find Full Text PDF